Navidea Biopharma (NAVB): FDA Approves Expanded Use of Lymphoseek

October 15, 2014 7:05 AM EDT Send to a Friend
Navidea Biopharmaceuticals, Inc. (NYSE: NAVB), a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced that the U.S. Food and ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login